To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer
Recruiting
N/A
Interventional Study
Breast Cancer
At a Glance
- Age
- 20 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 100 (estimated)
- Sponsor
- GenMont Biotech Incorporation · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Chemotherapy-associated side-effects would affect therapeutic effect, quality of life, and cause permanent harm to breast cancer patients. This study is designed to explore after consumption of probiotics of lactobacillus composite strain powder sachets for 6 months in breast cancer chemotherapy, and whether the improvement of meliorate the side effects, further assists patients completing the che…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Stage I-III breast patients using anthracycline-based and taxane-based chemotherapy (not limited before or after chemotherapy/surgery)
* BMI \> 18 kg/m\^2
* Age between 20 and 80 years old
* Patients judged by physicians to participate in this trial and who are willing
Exclus…
Contacts